Actively Recruiting
Pipeline Embolization for Intracranial Aneurysms
Led by Zhujiang Hospital · Updated on 2024-11-18
1000
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
Sponsors
Z
Zhujiang Hospital
Lead Sponsor
N
Nanfang Hospital, Southern Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.
CONDITIONS
Official Title
Pipeline Embolization for Intracranial Aneurysms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 22 and 75 years, male or non-pregnant female
- Diagnosed with unruptured intracranial aneurysm by CTA, MRA, or DSA
- Aneurysm size between 3 and 25 millimeters
- Understands the procedure and provides written informed consent
- Indications for flow-diverter implantation with or without adjunctive coiling
- Willing to return for follow-up visits according to the study protocol
You will not qualify if you...
- Contraindications to flow-diversion treatment or allergy to cobalt-chromium alloy or contrast medium
- Pregnancy or breastfeeding
- Presence of other vascular lesions such as coronary artery disease, abdominal aortic aneurysm, severe intracranial artery stenosis, arteriovenous malformation, dural arteriovenous fistula, or Moyamoya disease
- Parent vessel diameter less than 2.0 mm or 5.0 mm or greater
- Unwillingness to participate in follow-up or poor treatment compliance
- Life expectancy less than 3 years
- Inability to receive anti-platelet or anticoagulant medication
- Severe neurological deficit preventing independent living (modified Rankin score 4 or higher)
- Participation in another trial or other conditions deemed unsuitable by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhujiang hospital
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
C
Chuanzhi Duan, MD
CONTACT
X
Xin Feng, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here